User profiles for Urs Frey

Urs Frey

- Verified email at ukbb.ch - Cited by 23484

Urs Frey

- Verified email at mxwbio.com - Cited by 4154

[HTML][HTML] Revealing neuronal function through microelectrode array recordings

…, K Deligkaris, T Bullmann, DJ Bakkum, U Frey - Frontiers in …, 2015 - frontiersin.org
Microelectrode arrays and microprobes have been widely utilized to measure neuronal
activity, both in vitro and in vivo. The key advantage is the capability to record and stimulate …

Risk of severe asthma episodes predicted from fluctuation analysis of airway function

U Frey, T Brodbeck, A Majumdar, D Robin Taylor… - Nature, 2005 - nature.com
Asthma is an increasing health problem worldwide 1 , but the long-term temporal pattern of
clinical symptoms is not understood and predicting asthma episodes is not generally …

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

…, SE Dahlen, R Djukanovic, U Frey… - European respiratory …, 2014 - Eur Respiratory Soc
Severe or therapy-resistant asthma is increasingly recognised as a major unmet need. A
Task Force, supported by the European Respiratory Society and American Thoracic Society, …

[HTML][HTML] High-resolution CMOS MEA platform to study neurons at subcellular, cellular, and network levels

…, IL Jones, M Fiscella, R Diggelmann, A Stettler, U Frey… - Lab on a Chip, 2015 - pubs.rsc.org
Studies on information processing and learning properties of neuronal networks would benefit
from simultaneous and parallel access to the activity of a large fraction of all neurons in …

Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach

…, E Eber, ML Everard, U Frey… - European …, 2008 - Eur Respiratory Soc
There is poor agreement on definitions of different phenotypes of preschool wheezing disorders.
The present Task Force proposes to use the terms episodic (viral) wheeze to describe …

After asthma: redefining airways diseases

…, A Custovic, FM Ducharme, JV Fahy, U Frey… - The Lancet, 2018 - thelancet.com
Asthma is responsible for considerable global morbidity and health-care costs. Substantial
progress was made against key outcomes such as hospital admissions with asthma and …

Fluctuation phenotyping based on daily fraction of exhaled nitric oxide values in asthmatic children

…, E Baraldi, S Carraro, C Thamrin, U Frey - Journal of allergy and …, 2011 - Elsevier
BACKGROUND: Fraction of exhaled nitric oxide (Feno), a marker of airway inflammation,
has been proposed to be useful for asthma management, but conclusions are inconsistent. …

Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission

…, GJ Criner, SC Dharmage, FME Franssen, U Frey… - The Lancet, 2022 - thelancet.com
Despite substantial progress in reducing the global impact of many non-communicable
diseases, including heart disease and cancer, morbidity and mortality due to chronic respiratory …

Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort

…, B Dahlén, SE Dahlen, K Dyson, U Frey… - European …, 2015 - Eur Respiratory Soc
U-BIOPRED is a European Union consortium of 20 academic institutions, 11 pharmaceutical
companies and six patient organisations with the objective of improving the understanding …

Management of severe asthma: a European respiratory society/American thoracic society guideline

…, A Custovic, R Djukanovic, U Frey… - European respiratory …, 2020 - Eur Respiratory Soc
This document provides clinical recommendations for the management of severe asthma.
Comprehensive evidence syntheses, including meta-analyses, were performed to summarise …